StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology total assets

Total assets on the balance sheet at the end of each period.

Nexalin Technology's total assets was $3.00M at Jun 30, 2026. For fiscal 2025 it was $4.64M, up 9.8% from the year before. The highest annual figure on record is $7.43M in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.64M+9.8%
FY2024Dec 31, 2024$4.22M+16.3%
FY2023Dec 31, 2023$3.63M-51.1%
FY2022Dec 31, 2022$7.43M+886.1%
FY2021Dec 31, 2021$753.70K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.00M-54.2%
Q1 FY2026Mar 31, 2026$3.69M+27.4%
Q4 FY2025Dec 31, 2025$4.64M+9.8%
Q3 FY2025Sep 30, 2025$5.13M-2.5%
Q2 FY2025Jun 30, 2025$6.56M+319.9%
Q1 FY2025Mar 31, 2025$2.90M+2.3%
Q4 FY2024Dec 31, 2024$4.22M+16.3%
Q3 FY2024Sep 30, 2024$5.26M+1.6%
Q2 FY2024Jun 30, 2024$1.56M-73.6%
Q1 FY2024Mar 31, 2024$2.83M-61.9%
Q4 FY2023Dec 31, 2023$3.63M-56.5%
Q2 FY2023Jun 30, 2023$5.18M+586.7%
Q1 FY2023Mar 31, 2023$5.93M–
Q4 FY2022Dec 31, 2022$7.43M–
Q3 FY2022Sep 30, 2022$8.35M–
Q4 FY2021Dec 31, 2021$753.70K–

More Nexalin Technology figures

See a number that looks wrong?